DigitalOcean Holdings Inc vs GeneDx Holdings Corp — how do they compare? DigitalOcean Holdings Inc trades at $126.54 (market cap $14.21B), while GeneDx Holdings Corp trades at $82.5 (market cap $2.44B). The key difference: DigitalOcean Holdings Inc is far larger — about 5.8× GeneDx Holdings Corp's market cap, and DigitalOcean Holdings Inc is trading nearer its 52-week high, GeneDx Holdings Corp nearer its low. Which is the better fit depends on your goals.
| DOCN | WGS | |
|---|---|---|
Market Cap | $14.21B | $2.44B |
Sector | Technology | Technology |
52-Week High | $181.29 | $167.51 |
52-Week Low | $29.99 | $34.51 |
Enterprise Value | $14.97B | $2.48B |
Signals from Pluang's Aura AI — not financial advice
DigitalOcean (DOCN) trades at $129.73, up 4.49% today, showing strong momentum with three consecutive quarterly earnings beats. The stock maintains a bullish technical outlook with support at $124 and resistance at $135. Revenue growth accelerated to 29% year-over-year in Q2 2026, driven by surging AI-native cloud demand, while maintaining robust 40% adjusted EBITDA margins. Analyst consensus remains strongly positive with a $173.71 price target representing 34% upside potential.
DOCN presents compelling growth exposure to the AI infrastructure boom with accelerating revenue and strong profitability, though elevated valuation multiples (P/E 54.94) and high leverage ($1.49B debt) warrant caution. The company's strategic positioning in AI inference workloads and raised 2026 guidance support continued upside, but investors should monitor competitive pressures and execution risks in the rapidly evolving cloud market.
No Aura AI signal available yet.
Trailing returns across standard periods
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.
Read more on DOCN →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →